HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jakob Vinten-Johansen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sloots, K. L. Articles by Dobson, G. P. Search for Related Content PubMed PubMed Citation Articles by Sloots, K. L. Articles by Dobson, G. P. Related Collections Myocardial protection

J Thorac Cardiovasc Surg 2007;133:1171-1178
© 2007 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology

Warm nondepolarizing adenosine and lidocaine cardioplegia: Continuous versus intermittent delivery

^a Department of Physiology and Pharmacology, Molecular Science Building, James Cook University, Townsville, Queensland, Australia
^b Cardiothoracic Research Laboratory, Carlyle Fraser Heart Center, Emory University, Atlanta, Ga.

Received for publication October 20, 2006; revisions received December 6, 2006; accepted for publication December 18, 2006.

^_* Address for reprints: Geoffrey P. Dobson, PhD, Molecular Science Building, James Cook University, Townsville, Queensland, Australia. (Email: geoffrey.dobson{at}jcu.edu.au).

Objective: Continuous infusion of warm to normothermic cardioplegia may limit the surgeon’s visual field, increase coronary vascular resistance, and lead to potassium-exacerbated ischemia-reperfusion damage. Our aim was to examine the versatility of a new normokalemic, nondepolarizing adenosine–lidocaine cardioplegia during continuous or intermittent infusion at 33°C and compare it with lidocaine cardioplegia.

Methods: Isolated, perfused rat hearts (n = 6 each group) were arrested at 33°C for 40 or 60 minutes with 200 µm of adenosine and 500 µm of lidocaine in Krebs-Henseleit buffer (10 mmol/L glucose, pH 7.6-7.7 at 37°C) or 500 µm of lidocaine in Krebs–Henseleit buffer for 60 minutes delivered at 60 mm Hg.

Results: Times to arrest were 7 to 10 seconds for the adenosine–lidocaine groups and 102 seconds for the lidocaine group (P < .05). Total cardioplegia volumes for intermittent (2 minutes every 18 minutes) and continuous deliveries were 122 to 159 mL and 699 to 922 mL for the 40- and 60-minute adenosine–lidocaine arrest protocols, respectively, and 136 mL for the 60-minute intermittent lidocaine group. In the last 2 minutes of the 40- and 60-minute arrest protocols, the coronary vascular resistance was not significantly different for the hearts arrested with adenosine and lidocaine (0.27–0.32 megadyne/sec/cm^–5). Significantly higher coronary vascular resistance was found in the lidocaine cardioplegia group (0.38 megadyne/sec/cm^–5). No significant differences were found between the continuous or intermittent adenosine–lidocaine delivery protocols. Hearts arrested with adenosine and lidocaine recovered 88% to 89% of aortic flow and 109% of coronary flow at 60 minutes of reperfusion after 40-minute arrest, and 77% to 86% of aortic flow and 98% to 109% of coronary flow at 60 minutes of reperfusion after 60-minute arrest. Lidocaine cardioplegia led to significantly lower aortic and coronary flows after 60-minute arrest compared with the intermittent adenosine–lidocaine group.

Conclusions: We conclude that adenosine–lidocaine cardioplegia can be delivered intermittently or continuously with similar functional recoveries after a 40- or 60-minute arrest at 33°C. Hearts receiving lidocaine cardioplegia took a significantly longer time to arrest, showed higher coronary vascular resistance, and achieved lower functional recovery than the 60-minute adenosine–lidocaine cardioplegia groups. Intermittent or continuous delivery of adenosine–lidocaine cardioplegia may offer an alternative to current surgical hyperkalemic cardioplegia at warm to normothermic temperatures.

This article has been cited by other articles:

				Y. Liu, S.-l. Zhang, W.-x. Duan, L.-p. Lei, S.-q. Yu, X.-h. Qian, and Z.-x. Jin The Myocardial Protective Effects of a Moderate-Potassium Blood Cardioplegia in Pediatric Cardiac Surgery: A Randomized Controlled Trial Ann. Thorac. Surg., October 1, 2012; 94(4): 1295 - 1301. [Abstract] [Full Text] [PDF]

				T. Wu, P. Dong, C. Chen, J. Yang, and X. Hou The Myocardial Protection of Polarizing Cardioplegia Combined With Delta-Opioid Receptor Agonist in Swine Ann. Thorac. Surg., June 1, 2011; 91(6): 1914 - 1920. [Abstract] [Full Text] [PDF]

				K. L. Sloots and G. P. Dobson Normokalemic adenosine-lidocaine cardioplegia: Importance of maintaining a polarized myocardium for optimal arrest and reanimation J. Thorac. Cardiovasc. Surg., June 1, 2010; 139(6): 1576 - 1586. [Abstract] [Full Text] [PDF]

				D. M. Rudd and G. P. Dobson Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm for orthotopic heart transplantation. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 198 - 207. [Abstract] [Full Text] [PDF]

				Z.-X. Jin, S.-L. Zhang, X.-M. Wang, S.-H. Bi, M. Xin, J.-J. Zhou, Q. Cui, W.-X. Duan, H.-B. Wang, and D.-H. Yi The myocardial protective effects of a moderate-potassium adenosine-lidocaine cardioplegia in pediatric cardiac surgery J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1450 - 1455. [Abstract] [Full Text] [PDF]